|1.||Zwierz, Krzysztof: 10 articles (01/2014 - 11/2006)|
|2.||Waszkiewicz, Napoleon: 7 articles (01/2014 - 01/2011)|
|3.||Olszewska, Ewa: 6 articles (01/2014 - 11/2006)|
|4.||Bonventre, Joseph V: 5 articles (11/2015 - 02/2006)|
|5.||Ouchi, Motoshi: 5 articles (04/2015 - 01/2012)|
|6.||Suzuki, Tatsuya: 5 articles (04/2015 - 01/2012)|
|7.||Oba, Kenzo: 5 articles (04/2015 - 01/2012)|
|8.||Caillaud, Catherine: 5 articles (08/2014 - 11/2005)|
|9.||Kępka, Alina: 5 articles (01/2014 - 01/2011)|
|10.||Szajda, Sławomir Dariusz: 5 articles (01/2014 - 01/2011)|
09/15/2015 - "We designed and synthesized two anomeric oleyl glucosaminides as anti-cancer agents where the presence of a trifluoroacetyl group close to the anomeric center makes them resistant to hydrolysis by hexosaminidases. "
09/01/2011 - "Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells."
09/01/1987 - "Finally, HOCC mediated degradation of radiolabeled ECM was discerned to be dependent upon active hexosaminidase action, since tumor cell mediated degradation of ECM could be inhibited by up to 60% in the presence of this synthetic competitive inhibitor. "
01/01/1985 - "N-Acetyl-beta-Glucosaminidase (NAG) activity was investigated in 50 intrathoracic tumors with a histochemical method. "
10/01/1984 - "Elevated levels of serum hexosaminidase (beta-2-acetamido-2-deoxy-D-glucoside; N-acetamidodeoxy-D-glucohydrolase, EC 220.127.116.11)(HEX) have been found in patients with cancer. "
01/01/1992 - "Serum B-N-acetyl hexosaminidase levels in rats with experimental acute pancreatitis, small-bowel ischemia, and small-bowel obstruction."
08/01/1992 - "A positive correlation was found (r = 0.66, P < 0.001) between the highest serum PLA2 activity, as measured early in the course of acute pancreatitis, and the highest N-acetyl-beta-glucosaminidase (NAG):creatinine ratio in the urine. "
02/01/2011 - "Marker enzymes [N-acetyl-β-D-glucosaminidase (NAG), cathepsin B and succinate dehydrogenase (SDH)] were assayed in subcellular fractions from control pancreas and in pancreatitis. "
01/01/1990 - "Intracellular localization and enzymatic activities of lysosomal enzymes (cathepsin B, N-acetyl-beta-glucosaminidase, and beta-glucuronidase) were studied in control rats and after induction of caerulein pancreatitis. "
01/01/1992 - "To evaluate the effects of acute pancreatitis on hepatic function and hepatic cellular and subcellular organellar fragility, we studied 1) the hepatic secretion of lysosomal enzymes (beta-glucuronidase, beta-galactosidase, and N-acetyl-beta-glucosaminidase) into bile in the isolated perfused rat liver model; 2) the aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), and lysosomal enzyme levels in the effluent in an isolated liver model; 3) hepatic lysosomal fragility in an in vitro incubation study; and 4) protective effects of a new low molecular weight synthetic protease inhibitor, ONO 3307, against hepatic injury in doses of 2 and 5 mg/kg.h in acute pancreatitis induced by a supramaximal dose of cerulein in rats. "
|3.||Renal Insufficiency (Renal Failure)
08/01/2008 - "In this study we compared the accuracy of urinary beta-2-microglobulin (U beta 2m) and N-acetyl-beta-glucosaminidase (U beta-NAG) in predicting renal insufficiency and remission rates. "
01/01/1989 - "Urinary beta-N-acetyl-D-glucosaminidase (NAG) activity increased from day 3 to day 5, then decreased to normal levels on day 7. Renal ATP concentration and energy charge decreased markedly on day 7. These data indicate that the blood oxygen supply to the tissues began to decrease on day 6 and that renal insufficiency developed in the terminal stage of infection. "
11/01/2011 - "We investigated the success rate after one session as well as urine N-acetyl-β-d-glucosaminidase (NAG) levels for the evaluation of renal injury according to shock wave frequency and pretreatment with low-energy shock waves during SWL. "
03/01/2004 - "Renal tubular damage can be assessed with the aid of urinary dosing of N-acetyl-beta-glucosaminidase (NAG) and it is possible to demonstrate a significant correlation between shock wave and damage to renal parenchyma. "
03/01/2004 - "Effect of shock wave reapplication on urinary N-acetyl-beta-glucosaminidase in canine kidney."
01/01/1983 - "Patients in the gram-negative septic shock group and the other shock group both had significantly greater glucosaminidase activity than controls. "
03/01/2002 - "Urine was collected for 8 h on the day before and immediately, 1, 7 and 28 days after shock wave exposure (SWE) for the measurement of urine volume, N-acetyl-beta-glucosaminidase (NAG), beta-2-microglobulin (beta2 M), and creatinine. "
07/01/2008 - "The positive outcome of urinary N-acetyl-beta-glucosaminidase was a bit high, but there were no associations between renal scar and urinary microprotein (P > 0.05). "
12/01/1992 - "Three enzyme/creatinine ratios (n-acetyl-B-D-glucosaminidase, gamma-glutamyl transferase and lactate dehydrogenase) were higher in children with reflux who had no renal scarring, but the degree of overlap with the normal range was such that it is doubtful whether any will be of use as a urinary marker."
01/01/1984 - "Activities of acid and alkaline phosphatases, cathepsin B, leucine aminopeptidase, N-acetyl-beta-D-hexosaminidases, beta-D-galactosidase and beta-D-glucuronidase were studied in leukocytes of two groups of patients with normal and pathological healing of wounds after surgical treatment of scar stenosis of larynx. "
|7.||Aspartate Aminotransferases (Aspartate Transaminase)
|8.||Alanine Transaminase (SGPT)
|10.||Protease Inhibitors (Protease Inhibitor)
|1.||Angioplasty (Angioplasty, Transluminal)
|2.||Lithotripsy (Extracorporeal Shockwave Lithotripsy)
|4.||Transplantation (Transplant Recipients)